A selective prostaglandin E2 receptor subtype 2 (EP2) antagonist increases the macrophage-mediated clearance of amyloid-beta plaques.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2015-06-24

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.jmedchem.5b00567PMID 26061158
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models.

  2015cited by this paper
• Lead Optimization Studies of Cinnamic Amide EP2 Antagonists

  2014cited by this paper
• Development of second generation EP2 antagonists with high selectivity.

  2014cited by this paper
• Prostanoid receptor EP2 as a therapeutic target.

  2014cited by this paper
• Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.

  2013cited by this paper
• Suppression of Inflammation with Conditional Deletion of the Prostaglandin E2 EP2 Receptor in Macrophages and Brain Microglia

  2013cited by this paper
• Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation

  2013cited by this paper
• Selectivity profiling of the novel EP2 receptor antagonist, PF‐04418948, in functional bioassay systems: atypical affinity at the guinea pig EP2 receptor

  2013cited by this paper
• Functional Impairment of Microglia Coincides with Beta-Amyloid Deposition in Mice with Alzheimer-Like Pathology

  2013cited by this paper
• Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2

  2012cited by this paper
• In vitro and in vivo characterization of PF‐04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist

  2011cited by this paper
• Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow.

  2010cited by this paper
• Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease

  2010cited by this paper
• Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice

  2008cited by this paper
• Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.

  2006cited by this paper
• Catalysts for Suzuki-Miyaura coupling processes: scope and studies of the effect of ligand structure.

  2005cited by this paper
• Ineffective phagocytosis of amyloid-β by macrophages of Alzheimer's disease patients

  2005cited by this paper
• Microglia lacking E Prostanoid Receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity.

  2005cited by this paper
• LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide.

  2005cited by this paper
• Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity

  2005cited by this paper
• Microglia in health and disease

  2005cited by this paper
• Deletion of the Prostaglandin E2 EP2 Receptor Reduces Oxidative Damage and Amyloid Burden in a Model of Alzheimer's Disease

  2005cited by this paper
• Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.

  2005cited by this paper
• A soluble base for the copper-catalyzed imidazole N-arylations with aryl halides.

  2005cited by this paper
• Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors.

  2005cited by this paper
• β-Amyloid-Stimulated Microglia Induce Neuron Death via Synergistic Stimulation of Tumor Necrosis Factor α and NMDA Receptors

  2005cited by this paper
• Microglia Lacking E Prostanoid Receptor Subtype 2 Have Enhanced Aβ Phagocytosis yet Lack Aβ-Activated Neurotoxicity

  2005cited by this paper
• Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMP12

  2004cited by this paper
• Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

  2003cited by this paper
• Microglia and inflammatory mechanisms in the clearance of amyloid β peptide

  2002cited by this paper
• The copper-catalyzed N-arylation of indoles.

  2002cited by this paper
• Neuronal oxidative damage from activated innate immunity is EP2 receptor‐dependent

  2002cited by this paper
• Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide.

  2002cited by this paper
• Prostanoid receptors: subtypes and signaling.

  2001cited by this paper
• Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy

  2001cited by this paper
• Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures.

  2001cited by this paper
• Development of a Generalized, Quantitative Physicochemical Model of CYP3A4 Inhibition for Use in Early Drug Discovery

  2001cited by this paper
• Odorless substitutes for foul-smelling thiols: syntheses and applications

  2001cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Elevated CSF prostaglandin E2 levels in patients with probable AD.

  1999cited by this paper
• Prostaglandin E Receptor Subtypes in Cultured Rat Microglia and Their Role in Reducing Lipopolysaccharide‐Induced Interleukin‐1 β Production

  1999cited by this paper
• Association of microglia with amyloid plaques in brains of APP23 transgenic mice.

  1999cited by this paper
• Microglial response to amyloid plaques in APPsw transgenic mice.

  1998cited by this paper
• Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors.

  1997cited by this paper
• Amyloid Fibrils Activate Tyrosine Kinase-Dependent Signaling and Superoxide Production in Microglia

  1997cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Neuritic plaque evolution in Alzheimer’s disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms

  1997cited by this paper
• Cellular aspects of the inflammatory response in Alzheimer's disease.

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• MHC class II‐positive microglia in human brain: Association with alzheimer lesions

  1992cited by this paper
• Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

  1989cited by this paper
• Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.

  1988cited by this paper
• Nitrogen insertion reactions of bridged bicyclic ketones. Regioselective lactam formation

  1981cited by this paper

• Antagonism of the EP2 Receptor Reveals Sex-Specific Protection in a Two-Hit Mouse Model of Alzheimer’s Disease

  2026cites this paper
• Visible-Light-Catalyzed Fast Synthesis of 1,4-Benzoxazepine Derivatives from 2-Alkoxyarylaldehydes and N-Arylglycines.

  2025cites this paper
• Neuroinflammation and Disease: Pathways and Opportunities.

  2025cites this paper
• Advances in the synthesis of aryl-fused six- to nine-membered N,O-heterocycles

  2025cites this paper
• Discovery of ACT‐1002‐4271 as a Dual Prostaglandin E2 Receptor 2/Prostaglandin E2 Receptor 4 Antagonist with In Vivo Anti‐Tumor Efficacy

  2025cites this paper
• Base-Mediated Synthesis of Imidazole-Fused 1,4-Benzoxazepines via 7-exo-dig Cyclizations: Propargyl Group Transformation

  2025cites this paper
• Palladium-Catalyzed Heteroannulation of Salicylamides with Propargyl Carbonates: Synthesis of 1,4-Benzoxazepin-5-ones.

  2024cites this paper
• Suppressing the Inflammatory Prostaglandin Signaling after Thrombotic Stroke Ameliorates Ischemic Brain Injury and Facilitates Poststroke Recovery.

  2024cites this paper
• Synthesis and biological evaluation of 4,7,9-trisubstituted benzoxazepines as antileishmanial agents.

  2024cites this paper
• Base-mediated [4 + 3] annulation of α-halogen hydroximate with o-QMs: Facile access to 1, 4-benzoxazepine scaffold

  2024cites this paper
• The discovery of cyclic γ-AApeptides as the promising ligands targeting EP2.

  2023cites this paper
• Design of Dual EP2/EP4 Antagonists through Scaffold Merging of Selective Inhibitors

  2023cites this paper
• The immunometabolic reprogramming of microglia in Alzheimer's disease.

  2023cites this paper
• Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis

  2023cites this paper
• Iridium-Catalyzed Intramolecular Asymmetric Allylic Etherification of Pyrimidinemethanols: Enantioselective Construction of Multifunctionalized Pyrimidine-Fused Oxazepines.

  2023cites this paper
• Metal-free and enantioselective synthesis of 1,4-benzoxazepines from para-quinone methide derivatives and α-bromohydroxamates.

  2023cites this paper
• Diversity-Oriented Synthesis of Benzo[f][1,4]oxazepine-, 2H-Chromene-, and 1,2-Dihydroquinoline-Fused Polycyclic Nitrogen Heterocycles under Microwave-Assisted Conditions.

  2023cites this paper
• EP2 inhibition restores myeloid metabolism and reverses cognitive decline

  2023cites this paper
• Antibacterial Activity of Small Molecules Which Eradicate Methicillin-Resistant Staphylococcus aureus Persisters

  2022cites this paper
• Preclinical development of an EP2 antagonist for post-seizure cognitive deficits.

  2022cites this paper
• Microwave-Assisted Copper(II)-Catalyzed Cascade Cyclization of 2-Propargylamino/Oxy-Arylaldehydes and O-Phenylenediamines: Access to Densely Functionalized Benzo[f]Imidazo[1,2-d][1,4]Oxazepines and Benzo[f]Imidazo[1,2-d][1,4]Diazepines.

  2022cites this paper
• Second-Generation Prostaglandin Receptor EP2 Antagonist, TG8-260, with High Potency, Selectivity, Oral Bioavailability, and Anti-Inflammatory Properties.

  2022cites this paper
• Enantioenriched α-Vinyl 1,4-Benzodiazepines and 1,4-Benzoxazepines via Enantioselective Rhodium-Catalyzed Hydrofunctionalizations of Alkynes and Allenes

  2021cites this paper
• Restoring metabolism of myeloid cells reverses cognitive decline in ageing

  2021cites this paper
• Metabolic Reprogramming Rejuvenates Aged Myeloid Cells Restoring Cognition

  2021cites this paper
• EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics.

  2021cites this paper
• Recent Progress Concerning the N-Arylation of Indoles

  2021cites this paper
• Pd-Catalyzed allylic C-H activation to seven-membered N,O-heterocycles.

  2021cites this paper
• Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer’s disease

  2021cites this paper
• Potent, selective, water soluble, brain-permeable EP2 receptor antagonist for use in central nervous system disease models.

  2020cites this paper
• Transition-metal-free synthesis of 1,4-benzoxazepines via [4+3]-cycloaddition of para-quinone methides with azaoxyallyl cations

  2020cites this paper
• An Agonist Dependent Allosteric Antagonist of Prostaglandin EP2 Receptors.

  2020cites this paper
• Columnar Propeller‐Like 1,3,5‐Triphenylbenzenes: Probing the Effect of Chlorine on the Suzuki Cross‐Coupling and Liquid Crystalline Properties

  2020cites this paper
• Prostaglandin E2 as a Therapeutic Target in Bladder Cancer: From Basic Science to Clinical Trials.

  2020cites this paper
• Structure-Activity Relationship Study on Col-003, a Protein-Protein Interaction Inhibitor between Collagen and Hsp47.

  2020cites this paper
• One-Pot Synthesis of Diverse Collections of Benzoxazepine and Indolopyrazine Fused to Heterocyclic Systems.

  2019cites this paper
• Synthesis of 4-Halo-3-isopropoxyfuro[3,4-с]-pyridin-1(3H)-ones

  2019cites this paper
• Domino Transformations of Ene/yne Tethered Salicylaldehyde Derivatives: Pluripotent Platforms for the Construction of High Sp3 Content and Privileged Architectures.

  2019cites this paper
• Challenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors

  2019cites this paper
• PGE2 signaling via the neuronal EP2 receptor increases injury in a model of cerebral ischemia

  2019cites this paper
• Impaired Autophagic Degradation of Transforming Growth Factor-β-Induced Protein by Macrophages in Lattice Corneal Dystrophy.

  2019cites this paper
• G protein-coupled receptors in acquired epilepsy: Druggability and translatability.

  2019cites this paper
• Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory Properties.

  2018cites this paper
• Optimization of synthetic route to PNA-T-OH monomers

  2018cites this paper
• Effect of Blast Exposure on Gene-Gene Interactions

  2018cites this paper
• Effect of Acute and Repeated Exposure to Traumatic Conditions on Gene Expression

  2018cites this paper
• Synthesis of 2-substituted benzo[b]thiophene via a Pd-catalyzed coupling of 2-iodothiophenol with phenylacetylene

  2017cites this paper
• A Stereoselective Route to Tetrahydrobenzoxazepines and Tetrahydrobenzodiazepines via Ring-Opening and Aza-Michael Addition of Activated Aziridines with 2-Hydroxyphenyl and 2-Aminophenyl Acrylates.

  2017cites this paper
• Modular Bi-Directional One-Pot Strategies for the Diastereoselective Synthesis of Structurally Diverse Collections of Constrained β-Carboline-Benzoxazepines.

  2017cites this paper
• Synthesis of Benzo[1,4]heterocycles using Palladium Catalyzed Heck Reaction to Vinylogous Carbonates/Carbamates: Unexpected Formation of Indoles via Carbopalladation Intercepted by Nucleopalladation.

  2017cites this paper
• The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization.

  2017cites this paper
• A Fluorination/Aryl Migration/Cyclization Cascade for the Metal-Free Synthesis of Fluoro-Benzoxazepines.

  2016cites this paper
• Development of Selective CBP/P300 Benzoxazepine Bromodomain Inhibitors.

  2016cites this paper
• Mechanism and Origin of the Unexpected Chemoselectivity in Fluorocyclization of o-Styryl Benzamides with a Hypervalent Fluoroiodane Reagent.

  2016cites this paper